Author:
Atilho Ruben M.,Perkins Kevin R.,Breaker Ronald R.
Abstract
Many bacteria use flavin mononucleotide (FMN) riboswitches to control the expression of genes responsible for the biosynthesis and transport of this enzyme cofactor or its precursor, riboflavin. Rare variants of FMN riboswitches found in strains of Clostridium difficile and some other bacteria typically control the expression of proteins annotated as transporters, including multidrug efflux pumps. These RNAs no longer recognize FMN, and differ from the original riboswitch consensus sequence at nucleotide positions normally involved in binding of the ribityl and phosphate moieties of the cofactor. Representatives of one of the two variant subtypes were found to bind the FMN precursor riboflavin and the FMN degradation products lumiflavin and lumichrome. Although the biologically relevant ligand sensed by these variant FMN riboswitches remains uncertain, our findings suggest that many strains of C. difficile might use rare riboswitches to sense flavin degradation products and activate transporters for their detoxification.
Funder
National Science Foundation
NIH
NIGMS
National Institutes of Health
Howard Hughes Medical Institute
Publisher
Cold Spring Harbor Laboratory
Reference61 articles.
1. Widespread Genetic Switches and Toxicity Resistance Proteins for Fluoride
2. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control
3. Blount KF . 2013. Methods for treating or inhibiting infection by Clostridium difficile. U.S. patent appl. no. 13/576,989.
4. Blount KF , Coish PDG , Dixon BR , Myung J , Osterman D , Wickens P , Avola S , Baboulas N , Bello A , Berman J , 2012. Flavin derivatives. U.S. patent appl. no. 13/381,809.
5. Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献